STENOTEX AQ50 - Stanozolol Suspension

Key Benefits of STENOTEX AQ50: Explosive power and speed: Increases strength, power, and agility, improving athletic performance in disciplines requiring explosiveness such as sprinting, weightlifting, and combat sports . Superior muscle definition: Promotes a dry, vascularized, and aesthetically defined physique, ideal for competitions and fitness photography. It is the preferred compound in pre-competition stages . Lean mass preservation: Maintains muscle tissue during severe caloric deficit stages, protecting muscle from catabolism while reducing body fat. No aromatization: Does not convert to estrogen, avoiding side effects such as gynecomastia and water retention. This characteristic makes it unique among injectable steroids . Maximum bioavailability: Micronized aqueous suspension presentation (without ester) allowing rapid and complete release of the active ingredient . Mild side effect profile: Considered one of the most tolerable anabolic steroids in terms of estrogenic side effects, with low impact on libido and overall well-being. Versatility: Effective for both men and women at appropriate dosages, being a safe option for users sensitive to side effects. Functional strength increase: Increases strength without significant weight gain, improving the strength-to-weight ratio. Ideal for athletes in weight-class disciplines. Accelerated recovery: Promotes protein synthesis and reduces recovery time between workouts, allowing for greater training frequency and intensity

How does STENOTEX AQ50 work? Stenotex AQ50 contains Stanozolol USP, an anabolic-androgenic steroid derived from dihydrotestosterone (DHT) with a unique structure that gives it exceptional properties: Protein synthesis: Increases protein synthesis in muscle tissue, promoting muscle growth and repair through androgen receptor activation . Nitrogen balance: Improves nitrogen balance, creating an anabolic state favorable for muscle maintenance and development. No aromatization: Does not convert to estrogen, meaning it does not cause water retention or estrogenic side effects. Stanozolol is resistant to aromatase . Low progestational activity: Unlike other steroids, stanozolol does not activate the progesterone receptor, avoiding side effects related to prolactin. SHBG inhibition: Reduces sex hormone binding globulin (SHBG) levels, increasing the free fraction of testosterone and other anabolic compounds . Anticatabolic effect: Acts as a potent anticatabolic agent, preserving muscle tissue during caloric deficit and metabolic stress states . Accelerated metabolism: Promotes fatty acid mobilization and oxidation, contributing to body fat loss and muscle definition. Short half-life: With a half-life of approximately 24 hours, its action is rapid and serum levels normalize quickly upon discontinuation

Usage Guide for STENOTEX AQ50: Administration route: Deep and slow intramuscular injection, preferably in the glute (upper outer quadrant) or deltoid. Shake vigorously before use to ensure uniform suspension of microparticles . Frequency: Due to its approximately 24-hour half-life, administration is recommended every 1-2 days or every third day to maintain stable plasma levels . Recommended dosage for men: 50 to 100 mg every 2-3 days (1 to 2 ampoules of STENOTEX AQ50). Typical cycles of 6 to 8 weeks. Recommended dosage for women: 25 to 50 mg every 3-4 days (1/2 to 1 ampoule of STENOTEX AQ50). Typical cycles of 4 to 6 weeks. It is one of the safest compounds for women due to its low androgenicity. Recommended cycle: Ideal for cutting protocols, pre-competition, and high-performance physical preparation. Excellent for 6-8 week cycles. Stacking: Frequently combined with compounds such as testosterone (at replacement doses), primobolan, trenbolone, or boldenone. Often used at the end of cycles to "harden" results. Post-cycle therapy (PCT): Post-cycle therapy is recommended to restore natural hormone levels. Typical 4-week protocol with Clomiphene (50 mg/day) or Tamoxifen (20 mg/day). Warning: Stanozolol is a substance prohibited by WADA at all times (in and out of competition) . Athletes subject to doping controls should refrain from its use. Consult with a healthcare professional before use. Perform periodic blood tests to monitor lipid profile and liver function . Precautions: Maintain adequate hydration and consider liver support (e.g., TUDCA, NAC) during the cycle. Discontinue use if signs of jaundice or cholestasis appear

Composition of STENOTEX AQ50: Active Ingredient: Micronized Stanozolol USP 50 mg per mL. High-purity compound with USP pharmaceutical grade . Chemical name: 17-methyl-2′H -5α-androst-2-eno[3,2-c]pyrazol-17β-ol . Vehicle: Sterile water for injection, creating an aqueous suspension that maximizes bioavailability of the active ingredient . Suspending agent: Polysorbate 80 and/or sodium carboxymethylcellulose to ensure uniform and stable suspension of microparticles. Preservative: Benzyl alcohol (1-2%) as a bacteriostatic agent, ensuring product stability and sterility . Presentation: 2 mL ampoules with 50 mg/mL concentration. Total of 100 mg of Stanozolol per ampoule (2 doses of 1 mL). Certification: Manufactured under USP (United States Pharmacopeia) and GMP (Good Manufacturing Practices) standards . Quality control: Purity and potency testing performed by certified independent laboratories using high-performance liquid chromatography (HPLC) and mass spectrometry. Purity: >98% purity, guaranteeing maximum quality and consistency in each batch. Storage: Store at controlled room temperature 20°-25°C (68°-77°F), in a dry place protected from light. Do not freeze. Shake before each use

Onset time and expected results: Onset time: Effects begin to be noticeable between 7 and 14 days of continuous use. The aqueous suspension presentation allows for rapid release of the active ingredient. Results at 2-4 weeks: Increased strength, improved muscle definition, greater vascularity, and sensation of muscle hardness. Improved post-workout recovery . Results at 4-6 weeks: Significant improvement in body composition, fat loss, and muscle mass maintenance. Drier, more defined, and vascularized physique. Results at 6-8 weeks: Dry, defined physique with superior muscle quality and maintained strength. Notable aesthetic results with maximum definition and vascularity. Expected results (8-week cycle at 50 mg/day or EOD): Lean muscle mass: Maintenance of mass (+0-1 kg in men) Strength increase in compound exercises: +5-15% Body fat reduction: 5-10% Definition and vascularity improvement: Notable - The compound is known for drastically improving muscle appearance Water retention: Minimal to none Estrogenic side effects: Absent ⚠️ Important clinical considerations: Stanozolol can cause elevated bilirubin and cholestasis, especially at high doses or prolonged use . The mean latency for liver injury symptoms is approximately 55 days . Periodic monitoring of liver function is recommended during the cycle

Clinical research and laboratory testing: Clinical studies: Stanozolol has been studied in multiple clinical trials, primarily in the treatment of anemia, hereditary angioedema, and weight loss conditions. Medical applications: Used in the treatment of: Hereditary angioedema Aplastic anemia and bone marrow suppression conditions Cachexia and malnutrition states Burns and severe trauma Safety profile: Considered one of the safest anabolic steroids in terms of estrogenic side effects. However, cholestatic liver toxicity has been documented in recreational users, with a mean latency of 55 days to symptom onset . Hepatotoxicity: Stanozolol, being a 17-α-alkylated compound, has been associated with cholestatic liver injury, hepatic necrosis, and in rare cases, fatal liver failure . Lipid profile effects: Stanozolol can significantly reduce HDL cholesterol and increase LDL, representing a cardiovascular risk factor . 3rd party testing: Our batches are subjected to purity and potency testing by certified independent laboratories using: High-performance liquid chromatography (HPLC) for purity Mass spectrometry for molecular identification Sterility and bacterial endotoxin testing Certifications: Manufactured under GMP (Good Manufacturing Practices) standards USP quality control (United States Pharmacopeia) Stability and shelf-life testing (24 months) Heavy metals and contaminant analysis Anti-doping warning: Stanozolol is included in the WADA 2025-2026 Prohibited List as S1.1 Anabolic Androgenic Steroids, prohibited at all times (in and out of competition) . Scientific references: Available upon request for healthcare professionals and high-performance athletes.